Showing results (351-360 of 673) with videos related to
Sort By:
Pageof 68
HIV Clinical Trials|October 9, 2001
Self-reported symptoms after initiation of a protease inhibitor in HIV-infected patients and their impact on adherence to HAARTS Duran, B Spire, F Raffi, et al.HIV Clinical Trials|October 9, 2001
Nevirapine or efavirenz combined with two nucleoside reverse transcriptase inhibitors compared to HAART: a meta-analysis of randomized clinical trialsD Torre, R Tambini, F SperanzaHIV Clinical Trials|October 9, 2001
Adherence to antiretroviral therapy: appropriate use of self-reporting in clinical practiceR J Pratt, N Robinson, H P Loveday, et al.HIV Clinical Trials|October 9, 2001
Comparative CD4 T-cell responses of reverse transcriptase inhibitor therapy with or without nelfinavir matched for viral exposureS Kravcik, A Magill, B Sanghvi, et al.HIV Clinical Trials|October 9, 2001
Combination therapy with indinavir, ritonavir, and delavirdine and nucleoside reverse transcriptase inhibitors in patients with HIV/AIDS who have failed multiple antiretroviral combinationsM Grodesky, E P Acosta, N Fujita, et al.HIV Clinical Trials|October 9, 2001
Improving participation in HIV clinical trials: impact of a brief interventionK A Freedberg, L Sullivan, A Georgakis, et al.HIV Clinical Trials|October 9, 2001
Progression to AIDS or death as endpoints in HIV clinical trialsF Raffi, G Chêne, R Lassalle, et al.HIV Clinical Trials|January 31, 2002
Differences in the detection of three HIV-1 protease inhibitors in non-blood compartments: clinical correlationsAlain Lafeuillade, Caroline Solas, Philippe Halfon, et al.HIV Clinical Trials|January 31, 2002
Electronic monitoring: adherence assessment or intervention?Glenn J Wagner, Bonnie Ghosh-DastidarHIV Clinical Trials|April 19, 2011
Factors associated with complete adherence to HIV combination antiretroviral therapyTimothy Juday, Shaloo Gupta, Kristy Grimm, et al.Pageof 68